NEWS

Recently, an amount of $40 million of series B financing ...

HP501, an URAT1 inhibitor being developed for the treatme...

April 12, 2019, the first patient of HC-1119 Phase III st...

Prev 1 2 Next
Hinova Pharmaceuticals Inc.

Founded in 2013 by a team of scientists with R&D and management experience from global multinational pharmaceutical and top CRO companies, Hinova Pharmaceuticals Inc. is a high-tech innovative drug discovery and development company dedicated to bring new medicines to patients worldwide. Our focus is on therapeutic areas where there are unmet medical needs.